As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) 2015, Eris Lifesciences has informed that all activities in relation to both, physical and electronic share transfer facilities for the Company are maintained during the period from 1st October, 2018 to 31st March, 2019 by the Company’s Registrar and Share Transfer Agent, viz., Link Intime India, which is registered as Registrar and Share Transfer Agent in Category - I with the Securities and Exchange Board of India vide registration No. INR000004058.
The above information is a part of company’s filings submitted to BSE.
